Roche to make Hemlibra donation to boost access

Swiss drugmaker Roche plans to donate its new hemophilia A drug Hemlibra to a program run by the World Hemophilia Federation, hoping to provide treatment to as many as 1,000 people in areas where patients face hurdles to treatment.